Literature DB >> 28848589

Withania somnifera: Advances and Implementation of Molecular and Tissue Culture Techniques to Enhance Its Application.

Vibha Pandey1, Waquar Akhter Ansari2, Pratibha Misra3, Neelam Atri2.   

Abstract

Withania somnifera, commonly known as Ashwagandha an important medicinal plant largely used in Ayurvedic and indigenous medicine for over 3,000 years. Being a medicinal plant, dried powder, crude extract as well as purified metabolies of the plant has shown promising therapeutic properties. Withanolides are the principal metabolites, responsible for the medicinal properties of the plant. Availability and amount of particular withanolides differ with tissue type and chemotype and its importance leads to identification characterization of several genes/ enzymes related to withanolide biosynthetic pathway. The modulation in withanolides can be achieved by controlling the environmental conditions like, different tissue culture techniques, altered media compositions, use of elicitors, etc. Among all the in vitro techniques, hairy root culture proved its importance at industrial scale, which also gets benefits due to more accumulation (amount and number) of withanolides in roots tissues of W. somnifera. Use of media compostion and elicitors further enhances the amount of withanolides in hairy roots. Another important modern day technique used for accumulation of desired secondary metabolites is modulating the gene expression by altering environmental conditions (use of different media composition, elicitors, etc.) or through genetic enginnering. Knowing the significance of the gene and the key enzymatic step of the pathway, modulation in withanolide contents can be achieved upto required amount in therapeutic industry. To accomplish maximum productivity through genetic enginnering different means of Withania transformation methods have been developed to obtain maximum transformation efficiency. These standardized transformation procedues have been used to overexpress/silence desired gene in W. somnifera to understand the outcome and succeed with enhanced metabolic production for the ultimate benefit of human race.

Entities:  

Keywords:  Ashwagandha; Withania somnifera; differentiation; metabolites; tissue culture; transformation; withanolides

Year:  2017        PMID: 28848589      PMCID: PMC5552756          DOI: 10.3389/fpls.2017.01390

Source DB:  PubMed          Journal:  Front Plant Sci        ISSN: 1664-462X            Impact factor:   5.753


Introduction

Withania somnifera (Ashwagandha; Solanaceae family) is one of the most recognized and studied medicinal plants due to its wide distribution all around the world. W. somnifera has been used for over 3,000 years in indigenous medicine (Ayurvedic) system (Scartezzini and Speroni, 2000; Kumar and Kalonia, 2007; Tuli and Sangwan, 2009; Singh et al., 2015b). Several studies collectively provide metabolic insight of more than 200 primary and secondary metabolic components of W. somnifera. Significance of Withania in therapeutic world has been recognized due to maximum accumulation and diversified form of withanolide. All the identified variants of withanolides became interesting for researchers due to their beneficial effects for human body (Figure 1A; Kumar et al., 2007; Kulkarni and Dhir, 2008; Sharada et al., 2008; Mirjalili et al., 2009; Singh et al., 2010; Dar et al., 2015).
Figure 1

(A) Some important therapeutic uses of Withania somnifera with few proposed mode of actions (Dar et al., 2015); (B) Possible metabolic pathway for withanolides and glycowithanolides (withanosides) production (Senthil et al., 2010; Dhar et al., 2013; Sabir et al., 2013; Singh et al., 2015b) [GA-3P, glyceraldehyde-3-phosphate; MEP, 2-methyl- D-erythritol 4-phosphate; DMAPP, dimethylalyl pyrophosphate; IPP, isopentenyl pyrophosphate; IPPI, isopentenyl diphosphate isomerise; HMG-CoA, 3-hydroxy-3-methylglutaryl-coenzyme A; DXP, 1-deoxy-D-xylulose 5-phosphate; MVAPK, mevalonate phosphate kinase; MVAPP, diphosphomevalonate decarboxylase; CDP-ME, 4-diphospho-cytidyl-2-methyl-D-erythritol; CMS, 4-(cytidine-5-diphospho)-2-C-tmethyl-Derythritol synthase; CMK, 4-(cytidine-5-diphospho)-2-C-methyl-D-erythritol kinase, CDP-MEP, 2-C-methyl- D-erythritol-2-phosphate; MCS, 2-C-methyl-D-erythritol-2,4-cyclodiphosphate synthase; HDS, Hydroxy methyl butenyl 4- diphosphate synthase; HMBPP, Hydroxy methyl butenyl 4-diphosphate; HDR, Hydroxy methyl butenyl 4-diphosphate reductase].

(A) Some important therapeutic uses of Withania somnifera with few proposed mode of actions (Dar et al., 2015); (B) Possible metabolic pathway for withanolides and glycowithanolides (withanosides) production (Senthil et al., 2010; Dhar et al., 2013; Sabir et al., 2013; Singh et al., 2015b) [GA-3P, glyceraldehyde-3-phosphate; MEP, 2-methyl- D-erythritol 4-phosphate; DMAPP, dimethylalyl pyrophosphate; IPP, isopentenyl pyrophosphate; IPPI, isopentenyl diphosphate isomerise; HMG-CoA, 3-hydroxy-3-methylglutaryl-coenzyme A; DXP, 1-deoxy-D-xylulose 5-phosphate; MVAPK, mevalonate phosphate kinase; MVAPP, diphosphomevalonate decarboxylase; CDP-ME, 4-diphospho-cytidyl-2-methyl-D-erythritol; CMS, 4-(cytidine-5-diphospho)-2-C-tmethyl-Derythritol synthase; CMK, 4-(cytidine-5-diphospho)-2-C-methyl-D-erythritol kinase, CDP-MEP, 2-C-methyl- D-erythritol-2-phosphate; MCS, 2-C-methyl-D-erythritol-2,4-cyclodiphosphate synthase; HDS, Hydroxy methyl butenyl 4- diphosphate synthase; HMBPP, Hydroxy methyl butenyl 4-diphosphate; HDR, Hydroxy methyl butenyl 4-diphosphate reductase]. Biosynthesis of metabolites could be improved effectively through genetic engineering, which requires full information of all the genes/enzymes involve in biosynthetic pathway. Using the limited reports available on genes as well as enzymes of W. somnifera, researchers have prosposed possible metabolic pathway for the synthesis of different withanolides (Figure 1B; Senthil et al., 2010; Dhar et al., 2013; Sabir et al., 2013). Genes, enzymes as well as metabolites of respective metabolic pathway show differential pattern of expression according to the plant part, age, season, and other environmental factors. Optimization of various tissue culture techniques become very important to explore W. somnifera at different aspects, as plants obtained from fileds are not enough for all in vitro studies. Therefore, efficient tissue culture techniques like, micropropogation, regeneration, organogenesis, hairy root production, etc. have been established. Also, development of transgenic plants has been considered as the most economical way to improve the yield of therapeutic metabolites on large scale. Present review recognizes the importance of W. somnifera and disscuss in detail genes/enzymes involved in the biosynthesis of secondary metabolites. The review also includes the significance of in vitro techniques in order to modulate the productivity of W. somnifera according to the desired final product. Suitable combinations of these findings create a very cooperative setting to modulate expression profile of various genes using different circumstances, results in synthesis of various secondary metabolites of W. somnifera.

Proposed pathways for biosynthesis of withanolides: medicinal component of W. somnifera

Withanolide biosynthesis involves the key upstream metabolic step of isoprenogenesis using isoprenoid as precursor. Isoprenogenesis is known to proceeds through two different independent pathways; mevalonic acid (MVA) and methylerythritol phosphate (MEP; also called deoxyxylulose pathway, DOXP) pathway (Chaurasiya et al., 2007; Sangwan et al., 2007). These pathways occur in cytosol and plastid, respectively and ultimately synthesizes the 30 carbon compound (triterpenoids), 24-methylene cholesterol (Figure 1B). Till date, complete information of whole withanolide biosynthesis pathway is not available. However, combination of several studies provide an overview of pathway illustrating several enzymatic steps (Mirjalili et al., 2009; Senthil et al., 2010; Chaurasiya et al., 2012; Gupta et al., 2013a,b, 2015; Dhar et al., 2015). Enzymatic steps of MVA and MEP pathways has been prescribed through the first transcriptome analysis of the plant (Senthil et al., 2010), which keeps improving with advancement in techniques (Gupta et al., 2013b, 2015; Senthil et al., 2015). These analyses reveal numbers of tissue specific unique sequences, differentially expressed genes related to biosynthesis of secondary metabolites.

Genes involved in biosynthesis of withanolides

Genes involved in biosynthesis of withanolides are Δ14-sterol reductase (EC 1.3.1.70), 1-deoxy-D-xylulose-5-phosphate reducto-isomerase/reductase (DXR; EC 1.1.1.267), 1-deoxy-D-xylulose-5-phosphate synthase (DXS; EC 2.2.1.7), 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (MEcPP synthase, IspF, EC 4.6.1.12), 2-C-methyl-D-erythritol 4-phosphate cytidylyl transferase (EC 2.7.7.60), 3-hydroxy-3-methylglutaryl-coenzymeA reductase (HMGR; EC 1.1.1.34), 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (EC 2.7.1.148), 4-hydroxy-3-methylbut-2-enyldiphosphate reductase (EC 1.17.1.2), 4-hydroxy-3-methylbut-2-enyldiphosphate synthase (HMB-PPS, IspG, EC 1.17.7.1), acetyl-CoA acetyltransferase (ACT, EC 2.3.1.9), C-5-sterol desaturase (C5SD, EC 1.14.19.20), cycloartenol C-24 methyltransferase (EC 2.1.1.142), cycloartenol synthase (CAS; EC 5.4.99.8), cycloeucalenol cycloisomerase (EC 5.5.1.9), cytochrome-P450s reductase (CPR, EC 1.6.2.4), farnesyl diphosphate synthase (FPPS, EC 2.5.1.10), geranyl diphosphate synthase (GPPS, EC 2.5.1.1), geranyl-geranyl diphosphate synthase (GGPPS, EC 2.5.1.29), glycosyltransferases (GT, EC 2.4.-), hydroxymethyl glutaryl-CoA synthase (HMGS, EC 2.3.3.10), isopentenyl diphosphate isomerase (IPPI, EC 5.3.3.2), methyltransferase (MT, EC 2.1.1.), mevalonate diphosphosphate decarboxylase (EC 4.1.1.33), mevalonate kinase (MVAK, EC 2.7.1.36), obtusifoliol 14-demethylase (EC 1.14.13.70), phosphomevalonate kinase (EC 2.7.4.2), squalene synthase (SQS, EC 2.5.1.21), squalene monooxygenase/epoxidase (SQE, 1.14.14.17), sterol Δ7 reductase (DWF, EC 1.3.1.21), etc. (Senthil et al., 2010, 2015; Gupta et al., 2013b, 2015). To understand the interactions of various molecular network in entirety, Dhar et al. (2015) and Singh et al. (2015b) summarized the available information of some in vitro studies with respect to regulation of pathway genes required for withanolide accumulation.

Few important catalytic conversions of proposed pathways

Among a number of enzymes, SQS and SQE are considered as an important enzymes in the biosynthesis of triterpenoids. Considering this, Gupta et al. (2012) characterize isoforms of SQS gene, while, Razdan et al. (2013) perform characterization and promoter analysis of SQE gene from W. somnifera. To confirm the functional activity, both studies also involved the cloning, expression and purification of gens/enzymes in E. coli. Genes encoding DXS, DXR and HMGR enzymes expressed their importance by catalyzing the key regulatory step of the isoprenoid biosynthesis. These genes revealed tissue specific, chemotype specific and modulated expression while exposed to SA, MeJA, as well as MI (Akhtar et al., 2013; Gupta et al., 2013c). Few members of sterol-GT (SGT) gene family of W. somnifera, have been recognized and characterized (Sharma et al., 2007; Madina et al., 2007a,b; Chaturvedi et al., 2012). SGTs are responsible for diversified glycosylation of sterols (including withanolides). The identified SGTs expressed different level of expression in different tissues as well as under different stress conditions, to proove their physiological importance (Sharma et al., 2007; Chaturvedi et al., 2011, 2012). Purified SGTs showed broad substrate specificity for sugar acceptor but not for the sugar donor (Madina et al., 2007a,b). Similar pattern of glycosylation was observed by Singh et al. (2013) during functional characterization of flavonoid-GT gene from W. somnifera.

Variation in gene expression pattern according to tissue and stress conditions

Relation among few pathway genes, withanolides accumulation with morphogenic transition has been studied by Sabir et al. (2013). In vitro tissues belongs to different stages of organogenesis (rhizogenesis and shoot organogenesis) were used for the experiment. Accumulation of major withanolides and expression of HMGR, FPP synthase (FPPS), SQS, SQE, cycloaretenol synthase (CAS), GTs were analyzed at different morphogenic transition states. Detailed study on four-CYP450 has been performed by Srivastava et al. (2015) to illustrate involvement of these enzyme in some specialized secondary metabolite (withanolides). The expression profiles of these CYPs showed chemotype-specific and tissue-specific variation, as well as variation in response to physiological and developmental factors. To expand the understanding of expression of genes in relation to withanolide biosynthetic pathway, Pal et al. (2016) perform experiments with different concentrations of fertilizers on fresh twigs of W. somnifera. Treated twigs related to highest accumulation of withaferin-A has been selected to analyse expression pattern of CYPs, allene oxide cyclases (AOCs) and few other pathway related genes.

Tissue culture studies on Withania somnifera

Seed germination in W. somnifera

Numerous, campylotropous, whitish, disk shaped seeds are found inside red or orange colored fruit (berry) of W. somnifera. Earlier reports mentioned high dormancy with poor seed viability (Khanna et al., 2013; Viji et al., 2013), also seeds of W. somnifera showed low and erratic germination with heterogeneous seedlings (Vashistha et al., 2010) having higher mortality rate of seedlings under field conditions (Khanna et al., 2013). The problems with seed germination of W. somnifera (in vitro and in field) guided the researchers toward finding of simple techniques with optimized conditions, in order to get faster and more germination rate. These conditions include nutrient medium, light conditions and condition of seeds, etc. These findings will help nursery workers and poor farmers interested in developing mass planting stock. Soaking of seeds in water, diluted sodium hypochlorite, nitrate solutions (of potassium, ammonium, cobalt, sodium, calcium and zinc), has been suggested to soften the hard seed coat of W. somnifera (Kattimani and Reddy, 2001; Vashistha et al., 2010). Improved germination has been observed at 25 ± 2°C and 16-h-light/8-h-dark photoperiod with the light intensity of 3,000 lux (Kambizi et al., 2006; Khanna et al., 2013; Viji et al., 2013). In addition to these conditions, incision on seed coat and few pre-incubation conditions (dark or 15°C) increases the germination percentage (Pandey et al., 2013; Viji et al., 2013; Kumar et al., 2016).

Regeneration and multiplication of W. somnifera

Seedlings, embryos, cotyledon, epicotyl, hypocotyl, petiole, leaves, nodes, internodes, stem, shoot tips and roots have been used in different experiments for callus induction, adventitious root induction, regeneration, differentiation, flower induction, and fruit setting (Sharada et al., 2008; Supe et al., 2011; Singh et al., 2017). Composition of gelling matrix was standardized for encapsulation of shoot tips of W. somnifera along with optimization of media composition (or soilrite) for conversion of encapsulated shoot tips into plantlets (Singh et al., 2006). Most studies with optimized in vitro tissue culture conditions of W. somnifera have been briefly summarized recently by Singh et al. (2017).

Accumulation of withanolides in different types of in vitro culture

The ultimate goal of different studies on W. somnifera is to provide maximum and better plant material for therapeutic purpose. These involes standardization of phytochemical analysis of different types of tissues obtained from different region and accession of W. somnifera, for accumulation of therapeutic metabolites (Table 1). On the basis of difference in available withanolides, W. somnifera has been divided into various chemotypes (accessions). Differences in chemo-profile of some selected chemotypes have been documented in several studies (Dhar et al., 2006; Kumar et al., 2007; Scartezzini et al., 2007; Bhatia et al., 2013).
Table 1

Different conditions/situation in order to accumulate therapeutically important metabolites of W. somnifera.

ConditionPlant PartSpecial treatment/condition/method/ identificationMetabolite extractedReferences
Standardization/ Identification of metabolic-analytical technique/ metaboliteIn situRoot; stem; leafHPLC for determination of withanolidesWS-1; WS-5Ganzera et al., 2003
Whole plantcholinesterase inhibiting withanolides2-new; 4- known withanolidesChoudhary et al., 2004
LeavesSulfated and oxygenated withanolides4-new; 6-known withanolidesMisra et al., 2005
Dried roots/ leavesHPLC and AFLP findings to relate different (15) accessionsWS-1; WS-2; WS-3; WS-7; WS-9; WSs; PGDhar et al., 2006
RootsRare dimeric withanolide (ashwagandhanolide)WS-1; WS-3; WS-7; WS-8; WS-14Subbaraju et al., 2006
Two new withanolides (TLC; NMR)2-new and 7-known withanolidesMisra et al., 2008
Leaves, rootsMore reliable HPLC to determine broad range of withanolides9- withanolidesChaurasiya et al., 2008
Various genotypesHPTLC for determination of withanolidesWS-1; WS-3; WS-10Srivastava et al., 2008
Leaves, rootsNMR and HPLC and GC–MS for metabolic fingerprinting48 to 62 primary/ secondary metaboliteChatterjee et al., 2010
Whole plant/ plant partsDistribution in various organsWS-3Praveen et al., 2010
Roots, fruits, leavesPhenolic acids5-phenolics; 3-flavonoids; few unknownAlam et al., 2011
Leaves, rootsHR-MAS-NMR to establish metabolic mapping (4 chemotypes)41 metabolitesBharti et al., 2011
Metabolic/ phytochemical profilingLeaves, stems, rootsMetabolomic characterization (NMR) from different (6) regionsPrimary and secondary metabolitesNamdeo et al., 2011
RootsDifferent species21 bioactive compoundsKumar et al., 2011
FruitsDevelopmental stages of fruit (NMR; COSYDQF; TOCSY; HSQC)17 metabolitesSidhu et al., 2011
Fruits (LC-HRMS and LC-MS/MS)62 metabolitesBolleddula et al., 2012
Chemotype (4) variations (GC–MS and NMR)82 metabolitesBhatia et al., 2013
Leaves, rootsClustering of accessions (25) based on phenotypic and chemotypic analysisWS-1; WS-2; WS-3Kumar et al., 2007
Relation between transcript and metabolic profile in two morpho-chemovariant accessionsWS-1; WS-2; WS-3Dhar et al., 2013
Different plant partsGrowth dependent variation in few metabolites (2 cultivars)WS-1; WS-2; WS-3; squaleneDhar et al., 2016
Media/soil/elicitortreatment/variationIn vitro; In situLeavesNitsch and Nitsch-(NN) media + BAP + IBAWS-1Furmanowa et al., 2001
Parts of seedlingsMS/ B5 basal media + (different combinations of plant hormones)WS-1; WS-2; WS-3; WS-4; WS-6Sharada et al., 2007
Leaves, stem, rootsMS + BAP, IAAWS-1; WS-3; WS-10Dewir et al., 2010
Leaves, roots, seedlingSandy loam soil; MSWS-1Johny et al., 2015
In vitroMultiple shoots, teratomaMS + BAP + KinetinWS-1; WS-3Sangwan et al., 2007
Multiple shootsMS + BAP+/ IAA+/ IBA+/ NAA+/ 2,4-DGlycowithanolides; withanolidesAhuja et al., 2009
Adventitious rootsMS + IBA + IAAWS-3Wasnik et al., 2009
MS + 2,4-D/ IAA/ IBA/ NAA; B5 NN; N6WS-3Praveen and Murthy, 2010
Adventitious roots from semi-friable callus of leavesMS + 2,4-D + kinetin, MS + IBA + IAAWS-1; WS-2; WS-3; WS-4; WS-10; WS-12; WS-13Sivanandhan et al., 2012a
MS + 2,4-D + kinetin, MS + IBA + NAA, ElicitorsWS-1; WS-3; WS-4; WS-12; WS-13Sivanandhan et al., 2012b
PlantletHoagland + MeJA; SAWS-1; WS-3Rana et al., 2013
Callus cultureMS + 2,4 D + kinetinWS-1; WS-3Chakraborty et al., 2013
Adventitious root cultureMS + sucrose + IBA; different concentrations/ types of sugars; different pHWS-3Murthy and Praveen, 2013
Cell suspension cultureMS + 40% Gracilaria edulis extract for 24 hWS-1; WS-2; WS-3; WS-4Sivanandhan et al., 2013b
Multiple shoot culturesMS + BAP + spermidineWS-1; WS-2; WS-3; WS-4Sivanandhan et al., 2013c
Cell suspension cultureMS + kinetin + L-glutamine + sucrose + CaCl2/ NH4Cl/ chitosan/ cholesterol/ MA/ squaleneWS-1; WS-2; WS-3; WS-4; WS-11; WS-12; WS-13Sivanandhan et al., 2014a
Shoot suspension cultureMS + Gracilaria edulis/ Sargassum wightiiWS-1; WS-2; WS-3; WS-4Sivanandhan et al., 2014b
Flowers, fruitsMS + BAP + IAA, sucrose, L-glutamine, adenine sulfate, nitrates of NH4+, K+, Na+WS-1; WS-2; WS-3; WS-4Sivanandhan et al., 2015c
In situWhole plant/ plant partsDifferent vermicompostsWS-1; WS-5Raja and Veerakumari, 2013
Leaves, rootsOrganic composion of soil (bioaugmented organic + gypsum)WS-1; WS-2; WS-3Gupta et al., 2016
SA; MeJA; MI (4 chemotypes)WS-3Gupta et al., 2011
In vitroin vitro cultureMeJA; GA3; YEWS-1; WS-2; WS-3Dhar et al., 2014
PlantletMeJA; SA; GA3WS-1; WS-2; WS-3Rana et al., 2014
MeJA; SA; 2,4-D; YEWS-1; WS-3Razdan et al., 2016
Strain-plasmid ± gene; tissue used for infection ofA. rhizogeneIn vitroHairy rootsLBA 9402 -pRi 1855; stem, leavesWS-5Ray et al., 1996
MTCC 2364, MTCC532; stem, hypocotyle, leavesNot mentionedPawar and Maheshwari, 2004
LBA 9402; A4-pRiA4; leavesWS-1; WS-5Bandyopadhyay et al., 2007
R1601- pRiA4b; different parts of seedlingWS-3Murthy et al., 2008
LBA9402/ A4 ± synthetic crypt gene; leavesWS-1Chaudhuri et al., 2009
15834; leavesWS-1; WS-3Doma et al., 2012
ATCC 15834, R1000, K599; leaves, petiole, internodesWS-1Saravanakumar et al., 2012
R1601; cotyledonary leavesWS-3Praveen and Murthy, 2013
R1000; leavesWS-1; WS-2; WS-3Sivanandhan et al., 2013a
A4 ± SGT; leavesWS-3Pandey et al., 2015
LBA9402 ±β-cryptogein gene; leavesWS-1; WS-3Sil et al., 2015
leavesWS-1; WS-2; WS-3; WS-4Sivanandhan et al., 2015b
R1000, MTCC 2364, MTCC 532; leavesWS-1; WS-3Thilip et al., 2015
A. tumefaciensIn vitroTeratomaNopaline:C58; octopine:Ach5, disarmed:LBA 4404; leavesWS-1; WS-5Ray and Jha, 1999
PlantletGV3102 - pIG121Hm ±CAS gene/ pGSA1131 ±RNAi; leavesTotal withanolideMishra et al., 2016
In situLeavesGV3102- pBI121 ±WsSQS; leavesWS-3Grover et al., 2013
Agroinfiltration (GV2260- pCAMBIA ±WsSQS) ± Microprojectile; leavesWS-1; WS-2; WS-3; WS-4Patel et al., 2014, 2015
LBA4404/GV3102 - pFGC1008/pBI121/TRV2/ ±SGT gene/s; leavesWS-1; WS-2; WS-3; WS-13Saema et al., 2015, 2016; Singh et al., 2016
LBA4404-pCAMBIA; leavesWS-1; WS-2; WS-3; WS-4Sivanandhan et al., 2015a

HPLC, high performance liquid chromatography; HPTLC, High performance thin layer chromatography; TLC, Thin layer chromatography; LC-MS, Liquid chromatography-mass spectrometry; NMR, Nuclear magnetic resonance; GC-MS, Gas chromatography mass spectrometry; FAB, Fast atom bombardment; HRMS, high resolution mass spectroscopy; COSYDQF, Two-dimensional (2D) phase-sensitive double quantum filtered correlation spectroscopy; TOCSY, Total correlation spectroscopy; HSQC, .

Different conditions/situation in order to accumulate therapeutically important metabolites of W. somnifera. HPLC, high performance liquid chromatography; HPTLC, High performance thin layer chromatography; TLC, Thin layer chromatography; LC-MS, Liquid chromatography-mass spectrometry; NMR, Nuclear magnetic resonance; GC-MS, Gas chromatography mass spectrometry; FAB, Fast atom bombardment; HRMS, high resolution mass spectroscopy; COSYDQF, Two-dimensional (2D) phase-sensitive double quantum filtered correlation spectroscopy; TOCSY, Total correlation spectroscopy; HSQC, . Variation persist in accumulation of withanolides due to plant parts, developmental stages (Praveen and Murthy, 2010; Dhar et al., 2013), plant part obtained from different types of cultures (Sharada et al., 2007; Singh et al., 2017) of W. somnifera. These studies establish relationship between morphology/condition of plant tissue and withanolide contents. Sivanandhan et al., 2012a,b, 2013b,c, 2014a,b, 2015a; Singh et al., 2017) used in vitro grown plants in different studies to develop adventitious roots, multiple shoots, shoot suspension culture, cell suspension culture, flowers, and fruits using different growth conditions. These developed tissues were harvested to extract different combinations of withanolides. Based on different studies, Singh et al. (2017) summarized effects of in vitro conditions on accumulation of withanolides. These studies involving organ and callus culture, cell suspension culture and Agrobacterium tumefaciens as well as A. rhizogene mediated transformation. Different conditions of these techniques resulted in modulated accumulation of different withanolides, some of which related to modulated gene expression pattern.

Hairy root culture of W. somnifera and withanolide accumulation

Hairy root cultures are a promising approach of bioprocess engineering for large scale production of valuable plant secondary metabolites. There are several reports available in order to modulate quantity of withanolides in hairy roots culture using A. rhizogenes mediated transformation (Pawar and Maheshwari, 2004; Bandyopadhyay et al., 2007; Murthy et al., 2008; Saravanakumar et al., 2012; Sivanandhan et al., 2013a, 2015b). It has been reported that different factors like carbohydrates (Doma et al., 2012), inorganic supplements (Praveen and Murthy, 2013), seaweed extracts (Gracilaria edulis and Sargassum wightii; Sivanandhan et al., 2015b), hormones, elicitation (like, chitosan, JA, SA; Chaudhuri et al., 2009; Doma et al., 2012; Sivanandhan et al., 2013a), etc. modulate biogeneration of withanolides in hairy root cultures. Difference in hairy root emergence was observed illustrating resistance or susceptibility of W. somnifera toward different strains of A. rhizogenes (Pawar and Maheshwari, 2004; Bandyopadhyay et al., 2007; Saravanakumar et al., 2012) as well as transformation efficiency of different explants used for the experiment (Murthy et al., 2008; Saravanakumar et al., 2012). Leaves proved to be more appropriate for infection by different strains of A. rhizogene, since used as explant in various studies (Ray et al., 1996; Bandyopadhyay et al., 2007; Chaudhuri et al., 2009; Doma et al., 2012; Saravanakumar et al., 2012; Praveen and Murthy, 2013; Sil et al., 2015; Thilip et al., 2015). Recenlty, Pandey et al. (2015) induced hairy root from leaf explants of W. somnifera expressing sterol glucosyltransferase gene (clone-4) using A. rhizogenes. The transgenic hairy roots were observed to accumulate higher amount of withanolide-A when subjected to elicitation (salicylic acid and methyl jasmonate).

A. tumefaciens mediated transformation and its application to modulated withanolide biosynthesis

Numerous studies have helped in developing efficient methods for regeneration of W. somnifera, while only few reports are available for genetic transformation for this medicinal plant (Singh et al., 2017). Altered expressions of genes related to biosynthetic pathway, ultimately modulate quantity of plant secondary metabolites, which are of therapeutic importance. Ray and Jha (1999) infected leaves of in vitro grown plants (two genotypes) with wild type nopaline and octopine strains of A. tumefaciens. Different types of galls obtained due to different levels of virulence on the two genotypes. Two principle withanolides, withanolide D and withaferin A extracted from shooty teratoma cultures in higher amount, while, withanolide D alone was detected in rooty teratomas. Pandey et al. (2010) performed successful A. tumefaciens mediated transformation with 1.67 efficiency using non-virulent strain. Leaves excised from 1-5-nodes of both in situ and in vitro grown 30 to 90-day-old seedlings of different accessions of W. somnifera were used for the study. LBA4404 containing the binary vector pIG121Hm showed more gus expression in second and third leaves of 75 day old seedlings. Leaf explants ultrasonicated at 47 KHz ± 6% for 10 s showed higher gus expression as compared to directly infected explants. The protocol was used to analyse in vivo enzymatic action of one SGT (WsSGTL1) of W. somnifera by Saema et al. (2015, 2016). RNAi silencing (Saema et al., 2015) as well as overexpression (Saema et al., 2016) of WsSGTL1 gene has been achieved in transgenic W. somnifera. As expected, reduction in the level of glycosylated products observed in transgenic with silenced WsSGTL1 transcript. However, transgenics with overexpressing WsSGTL1 showed early and enhanced growth, increased production of glycosterols, and glycowithanolides. These transgenics displayed biotic (Spodoptera litura) and abiotic (cold) stress tolerance as well as recovery after cold stress along with improved photosynthetic performance. Patel et al. (2014) established A. tumefaciens mediated transformation, microprojectile bombardment and microprojectile bombardment assisted agroinfection. Apical and nodal explants obtained from multiplied culture after in vitro seed germination were used as explants. Modified vector pCAMBIA1301 used to confirm transgene expression. Pre-cultured explants were bombarded and immediately infected with A. tumefaciens for microprojectile bombardment assisted agroinfection. The transformation efficiencies achieved were 3.86, 3.62, and 8.71%, through A. tumefaciens mediated, microprojectile bombardment and with the combination of both, respectively. The protocol (Patel et al., 2014) used to overexpress of WsSQS in W. somnifera (Patel et al., 2015). Grover et al. (2013) also transformed leaves and shoots of 4-6-weeks old seedlings with A. tumefaciens (GV3101 harboring pBI121H) containing SQS from W. somnifera. Transgenics were confirmed with enhance expression of WsSQS transcript and its enzymatic activity. Higher amount of different withanolides observed in transgenics to proove the involvement of SQS with enhanced withanolide biosynthesis. Nodal explants of 3-month old filed grown plants were used to develop transformation protocol of W. somnifera by Sivanandhan et al. (2015a) with 10% efficiency. These explant were found as an ideal tissue for the production of higher number of multiple shoots, hence adopted for the production transgenics. Explants were precultured (6-days) to obtain maximum transformation efficiency using Agrobacterium suspension (strain LBA4404 harboring pCAMIBA2301) at 0.2 OD600. The transformation frequency increased significantly with wounded nodal explants subjected to a sonication (10 s, longer treatment affected the viability of regenerating cells). Maximum transformation efficiency of 10.6% was observed by Mishra et al. (2015) using nodal explants infected with A. tumefaciens strain GV3101 harboring pIG121Hm. Explants were pre-cultured on MS supplemented with TDZ for 2 days and infected with Agrobacterium (0.2 OD600) for 20 min and co-cultivated for 48 h at 22°C. Virus induced gene silencing methods was adopted by several researchers to achive fast and efficient characterization of genes related to withanolide biosynthesis. Using this technology, successful silencing of SQS (Singh et al., 2015a), WsDWF-5 (Gupta et al., 2015) and three-WsSGTLs genes (Singh et al., 2016) were achived in W. somnifera. Ws-SQS silenced plants revealed positive and negative affects on expression of upstream asnd downstream pathway genes, which ultimately reduces the accumulation of phytosterols. Silencincing of WsDWF-5 was observed with reduced accumulation of withanolide while, 3-WsSGTLs gene silencing found associated with enhanced level of different withanolides and reduced level of glycowithanolides. Increased expression of other upstream genes of withanolide biosynthesis pathway also relates with the supressed activity of WsSGTLs, which leads to reduced tolerance toward biotic stress.

Conclusion

W. somnifera is of great importance in lots of medical conditions due to abundance of diversified therapeutic secondary metabolites (withanolides). Significance of the plant leads researchers to identify the best suitable way to enhace plant productivity according to increasing demands. In order to complete the requirement, complete information related to metabolites, their biosynthesis (pathway genes/enzymes) and effect of different factors (composition of soil/media, elicitors etc.) is essential. Under the influence of significance of biosynthetic pathway, related genes/enzymes and external factors, this review describes all analyzed combinations of molecular and/or in vitro techniques that modifies the accumulation of desired metabolites. Several environmental factors like, soil/media composition, different types of elicitors/stresses etc. affect the withanolide biosynthesis by regulation of gene expression pattern. A lot of investigations included in this review that analyse withanolide accumulation through different types of in vitro culture techniques, like, micropropagation, organogenesis, hairy root production etc. Combination of optimized in vitro techniques and information of pathway gene/enzyme are of great interest these days. Such combination of genetic transformation and optimized in vitro conditions provides much better productivity in terms of metabolite accumulation. The present review describes that there are a lot more combinations available and need to utilize in order to achieve best productivity, to make it easily accessible for the progress of medical industry.

Author contributions

VP and WA collected literature and wrote the manuscript, PM and NA critically evaluated the manuscript. All authors approved the manuscript.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  73 in total

1.  Regeneration of plants from alginate-encapsulated shoot tips of Withania somnifera (L.) Dunal, a medicinally important plant species.

Authors:  Ajay K Singh; Rachna Varshney; Manu Sharma; Shyam S Agarwal; Kailash C Bansal
Journal:  J Plant Physiol       Date:  2005-09-02       Impact factor: 3.549

2.  Withanolide production by root cultures of Withania somnifera transformed with Agrobacterium rhizogenes.

Authors:  S Ray; B Ghosh; S Sen; S Jha
Journal:  Planta Med       Date:  1996-12       Impact factor: 3.352

3.  Comprehensive metabolic fingerprinting of Withania somnifera leaf and root extracts.

Authors:  Sandipan Chatterjee; Shatakshi Srivastava; Asna Khalid; Niharika Singh; Rajender Singh Sangwan; Om Prakash Sidhu; Raja Roy; C L Khetrapal; Rakesh Tuli
Journal:  Phytochemistry       Date:  2010-05-17       Impact factor: 4.072

4.  Carbohydrate and elicitor enhanced withanolide (withaferin A and withanolide A) accumulation in hairy root cultures of Withania somnifera (L.).

Authors:  Madhavi Doma; Gauri Abhayankar; V D Reddy; P B Kavi Kishor
Journal:  Indian J Exp Biol       Date:  2012-07       Impact factor: 0.818

5.  Generation and analysis of expressed sequence tags from leaf and root of Withania somnifera (Ashwgandha).

Authors:  Kalaiselvi Senthil; Neha G Wasnik; Yu-Jin Kim; Deok-Chun Yang
Journal:  Mol Biol Rep       Date:  2009-08-09       Impact factor: 2.316

6.  Metabolic shift from withasteroid formation to phenylpropanoid accumulation in cryptogein-cotransformed hairy roots of Withania somnifera (L.) Dunal.

Authors:  Bipradut Sil; Chiranjit Mukherjee; Sumita Jha; Adinpunya Mitra
Journal:  Protoplasma       Date:  2014-12-23       Impact factor: 3.356

7.  Virus-induced gene silencing of Withania somnifera squalene synthase negatively regulates sterol and defence-related genes resulting in reduced withanolides and biotic stress tolerance.

Authors:  Anup Kumar Singh; Varun Dwivedi; Avanish Rai; Shaifali Pal; Sajjalavarahalli Gangireddy Eswara Reddy; Dodaghatta Krishnarao Venkata Rao; Ajit Kumar Shasany; Dinesh A Nagegowda
Journal:  Plant Biotechnol J       Date:  2015-03-24       Impact factor: 9.803

8.  Purification and physico-kinetic characterization of 3beta-hydroxy specific sterol glucosyltransferase from Withania somnifera (L) and its stress response.

Authors:  Bhaskara Reddy Madina; Lokendra Kumar Sharma; Pankaj Chaturvedi; Rajender Singh Sangwan; Rakesh Tuli
Journal:  Biochim Biophys Acta       Date:  2007-01-08

9.  A promising approach on biomass accumulation and withanolides production in cell suspension culture of Withania somnifera (L.) Dunal.

Authors:  Ganeshan Sivanandhan; Gnanajothi Kapil Dev; Murugaraj Jeyaraj; Manoharan Rajesh; Manickam Muthuselvam; Natesan Selvaraj; Markandan Manickavasagam; Andy Ganapathi
Journal:  Protoplasma       Date:  2012-12-18       Impact factor: 3.356

10.  Molecular characterization of two A-type P450s, WsCYP98A and WsCYP76A from Withania somnifera (L.) Dunal: expression analysis and withanolide accumulation in response to exogenous elicitations.

Authors:  Satiander Rana; Wajid Waheed Bhat; Niha Dhar; Shahzad A Pandith; Sumeer Razdan; Ram Vishwakarma; Surrinder K Lattoo
Journal:  BMC Biotechnol       Date:  2014-11-23       Impact factor: 2.563

View more
  4 in total

Review 1.  Bioprospecting Plant Growth Promoting Rhizobacteria for Enhancing the Biological Properties and Phytochemical Composition of Medicinally Important Crops.

Authors:  Asfa Rizvi; Bilal Ahmed; Mohammad Saghir Khan; Hossam S El-Beltagi; Shahid Umar; Jintae Lee
Journal:  Molecules       Date:  2022-02-19       Impact factor: 4.411

2.  Jasmonate responsive transcription factor WsMYC2 regulates the biosynthesis of triterpenoid withanolides and phytosterol via key pathway genes in Withania somnifera (L.) Dunal.

Authors:  Arti Sharma; Gulzar A Rather; Prashant Misra; Manoj K Dhar; Surrinder K Lattoo
Journal:  Plant Mol Biol       Date:  2019-05-14       Impact factor: 4.076

Review 3.  Root Cultures, a Boon for the Production of Valuable Compounds: A Comparative Review.

Authors:  Masooma Jawad Hussain; Yawar Abbas; Naushaba Nazli; Sara Fatima; Samantha Drouet; Christophe Hano; Bilal Haider Abbasi
Journal:  Plants (Basel)       Date:  2022-02-05

4.  Structural Characterization of Withanolide Glycosides from the Roots of Withania somnifera and Their Potential Biological Activities.

Authors:  Ji Won Ha; Jae Sik Yu; Bum Soo Lee; Dong-Min Kang; Mi-Jeong Ahn; Jung Kyu Kim; Ki Hyun Kim
Journal:  Plants (Basel)       Date:  2022-03-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.